The polycystic ovary syndrome associated with morbid obesity may resolve after weight loss induced by bariatric surgery

Journal of Clinical Endocrinology and Metabolism

Volumn 90, Issue 12, 2005, Pages 6364-6369

  Escobar Morreale, Héctor F ^a   Botella Carretero, José I ^a   Álvarez Blasco, Francisco ^a   Sancho, José ^a   San Millán, José L ^a  

^a HOSPITAL RAMÓN Y CAJAL   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROSTENEDIONE; PRASTERONE SULFATE; TESTOSTERONE;

ARTICLE; BARIATRIC SURGERY; CLINICAL ARTICLE; FEMALE; HIRSUTISM; HOMEOSTASIS; HUMAN; HYPERANDROGENISM; INSULIN RESISTANCE; MENSTRUAL CYCLE; MENSTRUATION; MORBID OBESITY; OVARY POLYCYSTIC DISEASE; OVULATION; PREMENOPAUSE; PRIORITY JOURNAL; TIME; WEIGHT REDUCTION;

ADULT; BARIATRIC SURGERY; CROSS-SECTIONAL STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; LONGITUDINAL STUDIES; OBESITY, MORBID; POLYCYSTIC OVARY SYNDROME; PROSPECTIVE STUDIES; REMISSION INDUCTION; WEIGHT LOSS;

EID: 28744439379     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2005-1490     Document Type: Article

References (35)

1. Asunción M, Calvo RM, San Millán JL, Sancho J, Avila S, Escobar-Morreale HF 2000 A prospective study of the prevalence of the polycystic ovary syndrome in unselected Caucasian women from Spain. J Clin Endocrinol Metab 85:2434-2438
2. Nelson VL, Legro RS, Strauss III JF, McAllister JM 1999 Augmented androgen production is a stable steroidogenic phenotype of propagated theca cells from polycystic ovaries. Mol Endocrinol 13:946-957
3. Nelson VL, Qin KN, Rosenfield RL, Wood JR, Penning TM, Legro RS, Strauss JF, McAllister JN 2001 The biochemical basis for increased testosterone production in theca cells propagated from patients with polycystic ovary syndrome. J Clin Endocrinol Metab 86:5925-5933
4. Dunaif A 1997 Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis. Endocr Rev 18:774-800
5. Gambineri A, Pelusi C, Vicennati V, Pagotto U, Pasquali R 2002 Obesity and the polycystic ovary syndrome. Int J Obes Relat Metab Disord 26:883-896
6. Apridonidze T, Essah PA, Iuorno MJ, Nestler JE 2005 Prevalence and characteristics of the metabolic syndrome in women with polycystic ovary syndrome. J Clin Endocrinol Metab 90:1929-1935
7. Crave JC, Fimbel S, Lejeune H, Cugnardey N, Dechaud H, Pugeat M 1995 Effects of diet and metformin administration on sex hormone-binding globulin, androgens, and insulin in hirsute and obese women. J Clin Endocrinol Metab 80:2057-2062
8. Crosignani PG, Colombo M, Vegetti W, Somigliana E, Gessati A, Ragni G 2003 Overweight and obese anovulatory patients with polycystic ovaries: parallel improvements in anthropometric indices, ovarian physiology and fertility rate induced by diet. Hum Reprod 18:1928-1932
9. Clark AM, Ledger W, Galletly C, Tomlinson L, Blaney F, Wang X, Norman RJ 1995 Weight loss results in significant improvement in pregnancy and ovulation rates in anovulatory obese women. Hum Reprod 10:2705-2712
10. Yanovski SZ, Yanovski JA 2002 Obesity. N Engl J Med 346:591-602
11. Norman RJ, Davies MJ, Lord J, Moran LJ 2002 The role of lifestyle modification in polycystic ovary syndrome. Trends Endocrinol Metab 13:251-257
12. Diamanti-Kandarakis E, Zapanti E 2000 Insulin sensitizers and antiandrogens in the treatment of polycystic ovary syndrome. Ann NY Acad Sci 900:203-212
13. Solomon CG, Dluhy RG 2004 Bariatric surgery-quick fix or long-term solution? N Engl J Med 351:2751-2753
14. Maggard MA, Shugarman LR, Suttorp M, Maglione M, Sugerman HJ, Livingston EH, Nguyen NT, Li Z, Mojica WA, Hilton L, Rhodes S, Morton SC, Shekelle PG 2005 Meta-analysis: surgical treatment of obesity. Ann Intern Med 142:547-559
15. Buchwald H, Avidor Y, Braunwald E, Jensen MD, Pories W, Fahrbach K, Schoelles K 2004 Bariatric surgery: a systematic review and meta-analysis. JAMA 292:1724-1737
16. Sjostrom L, Lindroos AK, Peltonen M, Torgerson J, Bouchard C, Carlsson B, Dahlgren S, Larsson B, Narbro K, Sjostrom CD, Sullivan M, Wedel H 2004 Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. N Engl J Med 351:2683-2693
17. National Institutes of Health Consensus Development Panel 1991 Gastrointestinal surgery for severe obesity. Ann Intern Med 115:956-961
18. Scopinaro N, Gianetta E, Civalleri D, Bonalumi U, Bachi V 1979 Biliopancreatic bypass for obesity: II. Initial experience in man. Br J Surg 66:618-620
19. Schirmer B 2000 Laparoscopic bariatric surgery. Surg Clin North Am 80:1253-1267
20. Zawadzki JK, Dunaif A 1992 Diagnostic criteria for polycystic ovary syndrome: Towards a rational approach. In: Dunaif A, Givens JR, Haseltine FP, Merriam GR, eds. Polycystic ovary syndrome. Boston: Blackwell; 377-384
21. Azziz R, Hincapie LA, Knochenhauer ES, Dewailly D, Fox L, Boots LR 1999 Screening for 21-hydroxylase-deficient nonclassic adrenal hyperplasia among hyperandrogenic women: a prospective study. Fertil Steril 72:915-925
22. Hatch R, Rosenfield RL, Kim MH, Tredway D 1981 Hirsutism: implications, etiology, and management. Am J Obstet Gynecol 140:815-830
23. Escobar-Morreale HF, Serrano-Gotarredona J, Varela C, García-Robles R, Sancho JM 1997 Circulating leptin concentrations in women with hirsutism. Fertil Steril 68:898-906
24. Escobar-Morreale HF, Lasuncion MA, Sancho J 2000 Treatment of hirsutism with ethinyl estradiol-desogestrel contraceptive pills has beneficial effects on the lipid profile and improves insulin sensitivity. Fertil Steril 74:816-819
25. Vermeulen A, Verdonck L, Kaufman JM 1999 A critical evaluation of simple methods for the estimation of free testosterone in serum. J Clin Endocrinol Metab 84:3666-3672
26. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC 1985 Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma insulin and glucose concentrations in man. Diabetologia 28:412-419
27. Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group 2004 Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod 19:41-47
28. Talbott EO, Zborowski JV, Rager JR, Boudreaux MY, Edmundowicz DA, Guzick DS 2004 Evidence for an association between metabolic cardiovascular syndrome and coronary and aortic calcification among women with polycystic ovary syndrome. J Clin Endocrinol Metab 89:5454-5461
29. Legro RS 2003 Polycystic ovary syndrome and cardiovascular disease: a premature association? Endocr Rev 24:302-312
30. SolomonCG1999 The epidemiology of polycystic ovary syndrome. Prevalence and associated disease risks. Endocrinol Metab Clin North Am 28:247-263
31. Fogel RB, Malhotra A, Pillar G, Pittman SD, Dunaif A, White DP 2001 Increased prevalence of obstructive sleep apnea syndrome in obese women with polycystic ovary syndrome. J Clin Endocrinol Metab 86:1175-1180
32. Sonino N, Fava GA, Mani E, Belluardo P, Boscaro M 1993 Quality of life of hirsute women. Postgrad Med J 69:186-189
33. Cronin L, Guyatt G, Griffith L, Wong E, Azziz R, Futterweit W, Cook D, Dunaif A 1998 Development of a health-related quality-of-life questionnaire (PCOSQ) for women with polycystic ovary syndrome (PCOS). J Clin Endocrinol Metab 83:1976-1987
34. Wing RR, Hill JO 2001 Successful weight loss maintenance. Annu Rev Nutr 21:323-341
35. McGuire MT, Wing RR, Hill JO 1999 The prevalence of weight loss maintenance among American adults. Int J Obes Relat Metab Disord 23:1314-1319